Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine;Accentuation des crises tonico-cloniques sous lamotrigine dans l'épilepsie myoclonique juvénile

Revue Neurologique

Volumn 162, Issue 11, 2006, Pages 1125-1127

  Maiga, Y ^a   Nogues, B ^a   Guillon, B ^a  

^a CHU de Nantes   (France)

Author keywords

Epilepsy; Juvenile myoclonic epilepsy; Lamotrigine

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG WITHDRAWAL; HUMAN; MALE; MYOCLONUS EPILEPSY; TONIC CLONIC SEIZURE;

EID: 33750699606     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75126-8     Document Type: Article

References (17)

1. BIRABEN A, ALLAIN H, SCARABIN JM, SCHÜCK S, EDAN G. (2000). Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology, 55: 1758.
2. BUCHANAN N. (1996). Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years. Seizure, 5: 209-214.
3. CARRAZANA EJ, WHEELER SD. (2001). Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology, 56: 1424-1425.
4. CATANIA S, CROSS H, DE SOUSA C, BOYD S. (1999). Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Epilepsia, 40: 1657-1660.
5. CERMINARA C, MONTANARO ML, CURATOLO P, SERI S. (2004). Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy. Neurology, 63: 373-375.
6. CRESPEL A, GENTON P, BERRAMDANE M, COUBES P, MONICARD C, BALDY-MOULINIER M, GELISSE P. (2005). Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology, 65: 762-764.
7. GENTON P, MCMENAMIN J. (1998). Aggravation of seizures by anti-epileptic drugs: what to do in clinical practice. Epilepsia, 39(suppl. 3): S26-S29.
8. GENTON P, GELISSE P, THOMAS P, DRAVET C. (2000). Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology, 55: 1106-1109.
9. GUERRINI R, DRAVET C, GENTON P, BELMONTE A, KAMINSKA A, DULAC O. (1998). Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia, 39: 508-512.
10. JANSZKY J, RASONYI G, HALASZ P, OLAJOS S, PERENYI J, SZUCS A, DEBRECZENI T. (2000). Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin Neuropharmacol, 23: 86-89.
11. MORRIS GL, HAMMER AE, KUSTRA RP, MESSENHEIMER JA. (2004). Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study. Epilepsy Behav, 5: 509-512.
12. PRASAD A, KUZNIECKY RI, KNOWLTON RC, WELTY TE, MARTIN RC, MENDEZ M, FAUGHT KE. (2003). Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 60: 1100-1105.
13. RYVLIN P, KAHANE P, SEMAH F, HIRSCH E, ARZIMANOGLOU A, THOMAS P. (2003). Faut-il prescrire les antiépileptiques de nouvelle géné ration en monothérapie de première intention dans les épilepsies nouvellement diagnostiquées de l'adolescent et de l'adulte ? Rev Neurol, 159: 936-941.
14. SULLIVAN JE, DLUGOS DJ. (2004). Idiopathic generalized Epilepsy. Curr Treat Options Neurol, 6: 231-242.
15. e édition), John Libbey, pp. 367-388.
16. WALLACE SJ. (1998). Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res, 29: 147-154.
17. WONG IC, MAWER GE, SANDER JW, LHATOO SD. (2001). A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy. Epilepsia, 42: 1354-1358.